Cargando…

High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users: Results From the TraP Hep C Program—A Prospective Nationwide, Population-Based Study

BACKGROUND: The Treatment as Prevention for Hepatitis C program started in 2016 in Iceland, offering treatment with direct-acting antivirals to hepatitis C virus (HCV)-infected individuals. Reinfections through injection drug use (IDU) can hamper elimination efforts. We determined reinfection rates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johannesson, Jon M, Fridriksdottir, Ragnheidur H, Löve, Thorvardur J, Runarsdottir, Valgerdur, Hansdóttir, Ingunn, Löve, Arthur, Thordardottir, Marianna, Hernandez, Ubaldo B, Olafsson, Sigurdur, Gottfredsson, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662175/ https://www.ncbi.nlm.nih.gov/pubmed/35438144 http://dx.doi.org/10.1093/cid/ciac272

Ejemplares similares

928. Major Decrease in Prevalence of Hepatitis C Viremia in Key Populations following the Second Year of Treatment as Prevention for Hepatitis C (TraP HepC) Program in Iceland
por: Gottfredsson, Magnus, et al.
Publicado: (2018)

2895. Threats to Successful Elimination of Viral Hepatitis: Results from the Nationwide Treatment as Prevention for Hepatitis C (TraP HepC) Program in Iceland
por: Gottfredsson, Magnus, et al.
Publicado: (2019)

Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland
por: Gottfredsson, Magnus, et al.
Publicado: (2017)

Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible
por: Palsson, Olafur, et al.
Publicado: (2019)

Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV
por: Young, Jim, et al.
Publicado: (2017)

Screening for Sexually Transmitted Infections During Hepatitis C Treatment to Predict Reinfection Among People With HIV
por: Hill, Lucas A, et al.
Publicado: (2020)

Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study
por: Bjarnason, Agnar, et al.
Publicado: (2018)

Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction
por: Reginsson, Gunnar W., et al.
Publicado: (2017)

Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
por: Sigurbergsdóttir, Aðalbjörg Ýr, et al.
Publicado: (2022)

P900: INVOLVED/UNINVOLVED SERUM FREE LIGHT CHAIN RATIO IS A STRONGER PREDICTOR OF DIAGNOSTIC/RISK FACTORS IN LIGHT CHAIN COMPARED TO HEAVY CHAIN MONOCLONAL GAMMOPATHIES
por: Thorir Oskarsson, Jon, et al.
Publicado: (2023)

Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study
por: Sigurbergsdóttir, Aðalbjörg Ýr, et al.
Publicado: (2023)

Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population
por: Saevarsdóttir, Karen Sól, et al.
Publicado: (2021)

Observational Study Evaluating the Seroprotection of HepB-alum Vaccine and HepB-CpG Vaccine in People With HIV
por: Reilly-Evans, Brenna, et al.
Publicado: (2023)

Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection
por: Maier, Hannah E, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Associates With Unstable Housing and Occurs in the Presence of Antibodies
por: Bean, David J, et al.
Publicado: (2021)

Impact of an Electronic Medical Record Best Practice Alert on Expedited Partner Therapy for Chlamydia Infection and Reinfection
por: Willis, Sarah J, et al.
Publicado: (2021)

Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study
por: Turbett, Sarah E, et al.
Publicado: (2022)

S. mansoni Trapping in Lungs Contributes to Resistance to Reinfection
por: Knopf, Paul Mark, et al.
Publicado: (2015)

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
por: Long, Thorir Einarsson, et al.
Publicado: (2022)

Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study
por: Lazarovits, Gilad, et al.
Publicado: (2022)

Post-COVID-19 Syndrome 2 Years After the First Wave: The Role of Humoral Response, Vaccination and Reinfection
por: Peghin, Maddalena, et al.
Publicado: (2023)

Herpes simplex encephalitis in Iceland 1987–2011
por: Dagsdóttir, Heiður Mist, et al.
Publicado: (2014)

Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections After a Second Wave With Predominance of Lambda in Lima and Callao, Peru
por: Pampa-Espinoza, Luis, et al.
Publicado: (2022)

The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial
por: Whalen, Meghan E, et al.
Publicado: (2022)

Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study
por: Safreed-Harmon, Kelly, et al.
Publicado: (2018)

Risk of New-Onset Long COVID Following Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: A Community-Based Cohort Study
por: Bosworth, Matthew L, et al.
Publicado: (2023)

coTRaCTE predicts co-occurring transcription factors within cell-type specific enhancers
por: van Bömmel, Alena, et al.
Publicado: (2018)

Reconciling Egg- and Antigen-Based Estimates of Schistosoma mansoni Clearance and Reinfection: A Modeling Study
por: Clark, Jessica, et al.
Publicado: (2021)

Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021–November 2021
por: Levin-Rector, Alison, et al.
Publicado: (2022)

Homotypic and Heterotypic Protection and Risk of Reinfection Following Natural Norovirus Infection in a Highly Endemic Setting
por: Chhabra, Preeti, et al.
Publicado: (2020)

Sixteen-year follow-up of childhood avalanche survivors
por: Thordardottir, Edda Bjork, et al.
Publicado: (2016)

Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM)
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2021)

P894: INFECTION RISK BEFORE DIAGNOSIS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: RESULTS FROM THE SCREENED POPULATION-BASED ISTOPMM STUDY
por: Ros Levy, Marina, et al.
Publicado: (2023)

Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index
por: Óskarsson, Jón Þórir, et al.
Publicado: (2023)

TraPS-VarI: Identifying genetic variants altering phosphotyrosine based signalling motifs
por: Ulaganathan, Vijay Kumar
Publicado: (2020)

Mutational analysis of the C-terminal FATC domain of Saccharomyces cerevisiae Tra1
por: Hoke, Stephen M. T., et al.
Publicado: (2010)

The relationship between cancer and rheumatoid arthritis: still a large research agenda
por: Love, Thorvardur, et al.
Publicado: (2008)

The Interleukin 6 −174 C/C Genotype Predicts Greater Rhinovirus Illness
por: Doyle, William J., et al.
Publicado: (2010)

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
por: Rognvaldsson, Saemundur, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ec92ibdr2r1hub6toie6ojo3r4